Health Care [ 9/12 ] | Life Sciences Tools & Services [ 25/73 ]
NASDAQ | Common Stock
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum.
The company also offers delivery models that include full service, functional service provider, and hybrid service structures.
In addition, it delivers phase I " IV clinical trial management, clinical pharmacology, and consulting services.
Fortrea Holdings Inc. enters into a strategic collaboration with Emery Pharma to provide rapid lot-by-lot, 1-methyl-4-nitrosopiperazine (MNP) testing of rifampin, the preferred drug for drug-drug interaction studies, to certify impurities are below the Acceptable Intake Limit set byU. S.
Food and Drug Administration guidelines.
Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 12, 25 | 0.02 Increased by +150.00% | -0.06 Increased by +134.90% |
| Mar 10, 25 | 0.18 Decreased by -5.26% | 0.37 Decreased by -50.73% |
| Nov 11, 24 | 0.23 Increased by +253.33% | 0.25 Decreased by -8.00% |
| Aug 12, 24 | -0.03 Decreased by -105.77% | 0.08 Decreased by -137.50% |
| May 13, 24 | -0.04 Decreased by -108.81% | 0.01 Decreased by -500.00% |
| Mar 11, 24 | 0.19 | 0.24 Decreased by -20.83% |
| Nov 13, 23 | -0.15 | 0.16 Decreased by -193.75% |
| Aug 24, 23 | 0.52 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 651.30 M Decreased by -1.63% | -562.90 M Decreased by -457.33% | Decreased by -86.43% Decreased by -466.57% |
| Dec 31, 24 | 697.00 M Decreased by -10.11% | -64.80 M Decreased by -80.00% | Decreased by -9.30% Decreased by -100.25% |
| Sep 30, 24 | 674.90 M Decreased by -13.07% | -27.90 M Decreased by -112.98% | Decreased by -4.13% Decreased by -145.01% |
| Jun 30, 24 | 662.40 M Decreased by -16.47% | -138.40 M Decreased by -549.35% | Decreased by -20.89% Decreased by -637.95% |
| Mar 31, 24 | 662.10 M Decreased by -13.36% | -101.00 M Decreased by -770.69% | Decreased by -15.25% Decreased by -904.96% |
| Dec 31, 23 | 775.40 M Increased by +1.80% | -36.00 M Increased by +64.39% | Decreased by -4.64% Increased by +65.02% |
| Sep 30, 23 | 776.40 M Increased by +1.85% | -13.10 M Decreased by -121.62% | Decreased by -1.69% Decreased by -121.22% |
| Jun 30, 23 | 793.00 M Decreased by -0.01% | 30.80 M Decreased by -53.61% | Increased by +3.88% Decreased by -53.61% |